Status:
UNKNOWN
Endothelial Progenitor Cells in Cervical Cancer Patients Receiving Chemoradiation
Lead Sponsor:
Mackay Memorial Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-80 years
Brief Summary
Invasive carcinoma of the uterine cervix remains the most common invasive cancer in women in many countries. Concurrent chemoradiotherapy (CCRT) is now recommended as a standard treatment for locally ...
Detailed Description
Invasive carcinoma of the uterine cervix remains the most common invasive cancer in women in many countries. Concurrent chemoradiotherapy (CCRT) is now recommended as a standard treatment for locally ...
Eligibility Criteria
Inclusion
- Receiving chemoradiation
Exclusion
- Stage IVB
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00753610
Start Date
January 1 2007
End Date
December 1 2019
Last Update
August 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mackay Memorial Hospital
Taipei, Taiwan, 10449